Invalidity Of A Patent Claiming Antibodies Characterized By Their Function In View Of Amgen - Patent

Baxalta Inc. and Baxalta GmbH (Baxalta) appealed a district court decision that the claims of U.S. Patent No. 7,033,590 were invalid for lack of enablement.

Related Keywords

Baxalta Gmbh ,Amgen ,Circuit The Court ,Amgen Inc ,Supreme Court ,Genentech ,Genentech Inc ,Baxalta Inc ,Federal Circuit ,Mondaq ,Invalidity Ofa Patent Claiming Antibodies Characterized By Their Function In View Of Amgen ,Food ,Drugs ,Healthcare ,Life Sciences ,Iotechnology Amp Nanotechnology ,Intellectual Property ,Patent , ,